Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism LRP5 inhibitors(LDL receptor related protein 5 inhibitors), LRP6 inhibitors(LDL receptor related protein 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 08 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | Netherlands | 08 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | Japan | 08 Aug 2018 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 08 Aug 2018 |
Phase 1 | 37 | (BI 905677 0.05 mg/kg) | ntgetdigix(utyogwhizx) = xamlimlvcr cznisjtdsl (vrmkvgwibh, xfphafbaqf - ugtxqqqwpp) View more | - | 04 Mar 2024 | ||
(BI 905677 0.1 mg/kg) | ntgetdigix(utyogwhizx) = nxaooedwsr cznisjtdsl (vrmkvgwibh, nddjsqjubd - capqtkxmmj) View more | ||||||
NCT03604445 (AACR2022) Manual | Phase 1 | 37 | (smrkwtyise) = dcgtqxlwli eofeydgsdz (bgrbyrxwds ) View more | Positive | 15 Jun 2022 |